Paid Clinical Trials Baton Rouge
Discover 257 paid clinical trials in Baton Rouge, Louisiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fianlimab & CemiplimabA Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
Sponsor:
Regeneron Pharmaceuticals
Location:
Code:
NCT05800015
Conditions
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
fianlimab
cemiplimab
Pemetrexed
Paclitaxel
Carboplatin
Pembrolizumab & Sacituzumab TirxumotecanA Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06312137
Conditions
Non Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab tirumotecan
Pembrolizumab
Cisplatin
Pemetrexed
Gemcitabine
DostarlimabStudy of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Sponsor:
GlaxoSmithKline
Location:
Code:
NCT05855200
Conditions
Colonic Neoplasms
Neoplasms, Colon
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dostarlimab
CAPEOX
FOLFOX
Golazo®The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Sponsor:
Avantec Vascular
Location:
Code:
NCT06321575
Conditions
Peripheral Arterial Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Golazo® Peripheral Atherectomy System (Golazo® Peripheral AS)
Niraparib vs. TemozolomideA Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
Sponsor:
Ivy Brain Tumor Center
Location:
Code:
NCT06388733
Conditions
Glioblastoma
GBM
Brain Neoplasms, Adult, Malignant
Brain Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Niraparib
Temozolomide
Interested in new trials?
Get alerts for new trials in your area by subscribing now
VolrustomigA Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Sponsor:
AstraZeneca
Location:
Code:
NCT06129864
Conditions
Locally Advanced Head and Neck Squamous Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
volrustomig
LuspaterceptELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT05949684
Conditions
Myelodysplastic Syndromes
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Luspatercept
Epoetin Alfa
Atezolizumab & BevacizumabA Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis
Sponsor:
Genentech, Inc.
Location:
Code:
NCT06096779
Conditions
Hepatocellular Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Atezolizumab
Bevacizumab
SurvodutideA Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity
Sponsor:
Boehringer Ingelheim
Location:
Code:
NCT06745284
Conditions
Obesity
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Survodutide
Semaglutide
BarzolvolimabA Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
Sponsor:
Celldex Therapeutics
Location:
Code:
NCT06455202
Conditions
Chronic Spontaneous Urticaria
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
barzolvolimab
Matching placebo